Advertisement

Cardiff Oncology, Inc. CRDF

Set alert

Price alert · CRDF

All alert types
0.89 USD -0.02 -2.46%

At close · Oct 30

0.87 -0.02 -1.99%

After hours · Oct 30, 4:00 PM ET

Bid
0.88 × 200
Ask
0.90 × 1
0.8582 Day range 0.9212
0.80 52-week range 3.21
YTD
-68.34%
1 year
-60.11%
Open
0.9001
Prev close
0.912
Mkt cap
69.21M
Vol
126.88K
Avg vol
668.14K
EPS
-0.60
P/E
0.00
Div yield
0.00%
More statistics
Low
0.8582
High
0.9212
Forward P/E
-4.03
Beta
1.93
Short ratio
8.06
Inst. own
27.66%
Dividend
0.00
Ex-div date
50-d avg
3.08
200-d avg
3.20
1y target
10.75

5D chart

Chart tools
Interval

Signals (124)
NameTimeAgo
SMA: BullishOct 30, 3:15 PM1 day ago
MACD: Buy SignalOct 30, 3:10 PM1 day ago
SMA: BullishOct 30, 3:05 PM1 day ago
SMA: BearishOct 30, 2:50 PM1 day ago
SMA: BullishOct 30, 2:40 PM1 day ago
MACD: Sell SignalOct 30, 1:55 PM1 day ago
SMA: BearishOct 30, 1:30 PM1 day ago
SMA: BullishOct 30, 1:15 PM1 day ago
SMA: BearishOct 30, 1:05 PM1 day ago
SMA: BearishOct 30, 1:05 PM1 day ago
SMA: BullishOct 30, 12:55 PM1 day ago
SMA: BullishOct 30, 12:30 PM1 day ago
MACD: Buy SignalOct 30, 12:30 PM1 day ago
MACD: Sell SignalOct 30, 12:15 PM1 day ago
SMA: BearishOct 30, 11:55 AM1 day ago
MACD: Buy SignalOct 30, 11:55 AM1 day ago
SMA: BullishOct 30, 11:50 AM1 day ago
SMA: BearishOct 30, 11:40 AM1 day ago
SMA: BullishOct 30, 11:35 AM1 day ago
SMA: BearishOct 30, 9:50 AM2 days ago
SMA: BearishOct 30, 9:50 AM2 days ago
SMA: BullishOct 30, 9:45 AM2 days ago
SMA: BullishOct 30, 9:45 AM2 days ago
SMA: BearishOct 29, 3:25 PM2 days ago
SMA: BullishOct 29, 3:20 PM2 days ago
SMA: BearishOct 29, 3:00 PM2 days ago
SMA: BearishOct 29, 3:00 PM2 days ago
MACD: Sell SignalOct 29, 3:00 PM2 days ago
MACD: Buy SignalOct 29, 2:45 PM2 days ago
SMA: BullishOct 29, 2:40 PM2 days ago
SMA: BullishOct 29, 2:40 PM2 days ago
SMA: BearishOct 29, 1:20 PM2 days ago
MACD: Sell SignalOct 29, 1:20 PM2 days ago
SMA: BearishOct 29, 12:50 PM2 days ago
MACD: Buy SignalOct 29, 11:40 AM2 days ago
SMA: BullishOct 29, 11:20 AM2 days ago
SMA: BearishOct 29, 11:05 AM3 days ago
SMA: BearishOct 29, 11:05 AM3 days ago
SMA: BullishOct 29, 11:00 AM3 days ago
SMA: BullishOct 29, 11:00 AM3 days ago
SMA: BearishOct 29, 10:25 AM3 days ago
SMA: BearishOct 29, 10:25 AM3 days ago
MACD: Sell SignalOct 29, 10:25 AM3 days ago
MACD: Buy SignalOct 29, 10:15 AM3 days ago
SMA: BullishOct 29, 10:10 AM3 days ago
SMA: BullishOct 29, 10:10 AM3 days ago
SMA: BearishOct 29, 10:05 AM3 days ago
SMA: BearishOct 29, 10:05 AM3 days ago
MACD: Sell SignalOct 29, 10:05 AM3 days ago
SMA: BullishOct 29, 9:55 AM3 days ago
SMA: BullishOct 29, 9:55 AM3 days ago
SMA: BearishOct 29, 9:45 AM3 days ago
SMA: BearishOct 29, 9:45 AM3 days ago
SMA: BullishOct 29, 9:35 AM3 days ago
SMA: BullishOct 29, 9:35 AM3 days ago
MACD: Buy SignalOct 29, 9:35 AM3 days ago
MACD: Sell SignalOct 29, 9:30 AM3 days ago
SMA: BearishOct 28, 3:55 PM3 days ago
SMA: BearishOct 28, 3:55 PM3 days ago
RSI: OverboughtOct 28, 3:50 PM3 days ago
MACD: Buy SignalOct 28, 3:45 PM3 days ago
SMA: BullishOct 28, 2:45 PM3 days ago
SMA: BullishOct 28, 2:45 PM3 days ago
SMA: BearishOct 28, 2:20 PM3 days ago
SMA: BearishOct 28, 2:05 PM3 days ago
SMA: BullishOct 28, 2:00 PM3 days ago
SMA: BearishOct 28, 1:35 PM3 days ago
MACD: Sell SignalOct 28, 1:35 PM3 days ago
SMA: BullishOct 28, 1:20 PM3 days ago
MACD: Buy SignalOct 28, 1:20 PM3 days ago
SMA: BearishOct 28, 1:15 PM3 days ago
SMA: BullishOct 28, 1:05 PM3 days ago
SMA: BearishOct 28, 12:45 PM3 days ago
MACD: Sell SignalOct 28, 12:45 PM3 days ago
SMA: BullishOct 28, 12:30 PM3 days ago
SMA: BearishOct 28, 12:25 PM3 days ago
SMA: BullishOct 28, 12:15 PM3 days ago
SMA: BearishOct 28, 12:05 PM3 days ago
MACD: Buy SignalOct 28, 10:50 AM4 days ago
SMA: BullishOct 28, 10:35 AM4 days ago
SMA: BullishOct 28, 10:35 AM4 days ago
SMA: BearishOct 28, 10:00 AM4 days ago
SMA: BearishOct 28, 10:00 AM4 days ago
SMA: BullishOct 28, 9:45 AM4 days ago
SMA: BullishOct 28, 9:45 AM4 days ago
SMA: BullishOct 27, 3:55 PM4 days ago
SMA: BullishOct 27, 3:55 PM4 days ago
MACD: Sell SignalOct 27, 3:10 PM4 days ago
SMA: BearishOct 27, 3:05 PM4 days ago
SMA: BearishOct 27, 3:05 PM4 days ago
MACD: Buy SignalOct 27, 2:50 PM4 days ago
RSI: OverboughtOct 27, 2:50 PM4 days ago
SMA: BullishOct 27, 2:10 PM4 days ago
SMA: BullishOct 27, 2:10 PM4 days ago
SMA: BearishOct 27, 1:15 PM4 days ago
SMA: BearishOct 27, 12:55 PM4 days ago
MACD: Sell SignalOct 27, 12:55 PM4 days ago
RSI: OverboughtOct 27, 11:35 AM4 days ago
SMA: BullishOct 27, 10:40 AM5 days ago
SMA: BullishOct 27, 10:40 AM5 days ago
MACD: Buy SignalOct 27, 10:40 AM5 days ago
MACD: Sell SignalOct 27, 10:30 AM5 days ago
SMA: BearishOct 27, 10:20 AM5 days ago
SMA: BearishOct 27, 10:10 AM5 days ago
SMA: BullishOct 27, 10:05 AM5 days ago
SMA: BearishOct 27, 10:00 AM5 days ago
SMA: BullishOct 26, 3:55 PM5 days ago
SMA: BullishOct 26, 3:55 PM5 days ago
SMA: BearishOct 26, 3:35 PM5 days ago
SMA: BullishOct 26, 3:30 PM5 days ago
MACD: Buy SignalOct 26, 3:15 PM5 days ago
RSI: OversoldOct 26, 3:10 PM5 days ago
RSI: OversoldOct 26, 2:50 PM5 days ago
RSI: OversoldOct 26, 2:30 PM5 days ago
RSI: OversoldOct 26, 1:45 PM5 days ago
MACD: Sell SignalOct 26, 1:05 PM5 days ago
SMA: BearishOct 26, 12:55 PM5 days ago
SMA: BearishOct 26, 12:55 PM5 days ago
SMA: BullishOct 26, 12:40 PM5 days ago
SMA: BullishOct 26, 12:20 PM5 days ago
SMA: BearishOct 26, 12:15 PM5 days ago
SMA: BullishOct 26, 12:05 PM5 days ago
SMA: BearishOct 26, 11:50 AM5 days ago
SMA: BullishOct 26, 11:45 AM5 days ago

Key statistics

Market cap
270.75M
Enterprise value
161.85M
Trailing P/E
0.00
Forward P/E
-4.03
PEG ratio
0.00
Price / sales
393.54
Price / book
4.01
EPS (TTM)
-0.95
Beta
1.93
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
688.00K
Revenue growth
17.00%
Free cash flow
-19.85M
Total cash
57.67M
Total debt
1.69M
Return on equity
-67.57%
Shares outstanding
66.52M
Short % of float
16.40%
50-day average
3.08
200-day average
3.20

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 10.75 +1108.4% upside
Target (low)
10.00
Target (mean)
10.75
Target (high)
13.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate -0.24667.

Earnings history

Financials — quick view

All financials
CRDF Revenue — quarterly 104.00K
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CRDF Net income — quarterly -9.23M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CRDF EPS — quarterly -0.14
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

CRDF recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 2024-0.27-0.25+0.02+7.41%
Aug 8, 2024Jun 1, 2024-0.25-0.26-0.01-4.00%
May 2, 2024Mar 1, 2024-0.25-0.22+0.03+12.00%
Feb 29, 2024Dec 1, 2023-0.26-0.21+0.05+19.23%
Nov 2, 2023Sep 1, 2023-0.29-0.22+0.07+24.14%
Aug 9, 2023Jun 1, 2023-0.27-0.25+0.02+7.41%

Upgrades / downgrades

CRDF analyst upgrades and downgrades
DateFirmActionFromTo
Dec 13, 2024Piper SandlermainOverweightOverweight
Nov 8, 2024HC Wainwright & Co.mainBuyBuy
Sep 6, 2024Craig-Halluminit—Buy
May 6, 2024HC Wainwright & Co.reitBuyBuy
Mar 6, 2024HC Wainwright & Co.mainBuyBuy
Mar 1, 2024Piper SandlermainOverweightOverweight

About Cardiff Oncology, Inc.

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor to treatment a range of solid tumor cancers and KRAS/NRAS-mutated metastatic colorectal and metastatic pancreatic cancer, as well as investigator-initiated trials in triple negative breast cancer and small cell lung cancer; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on CRDF — it syncs with the Stock Master app.

Insider holders

CRDF insider holders
InsiderRelationLatest transactionDateShares held
ERLANDER MARKOfficerConversion of Exercise of derivative securityJan 1, 20206,376

Institution ownership

CRDF institution ownership
Holder% heldSharesValueReported
Blackrock Inc.5.35%2,735,58111.13MSep 29, 2024
Vanguard Group Inc4.25%2,171,4448.84MSep 29, 2024
Geode Capital Management, LLC1.82%928,2323.78MSep 29, 2024
State Street Corporation1.63%832,6523.39MSep 29, 2024
MAI Capital Management1.30%663,3632.70MSep 29, 2024
Renaissance Technologies, LLC1.18%602,3842.45MSep 29, 2024

Fund ownership

CRDF fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.45%1,254,7175.11MSep 29, 2024
iShares Russell 2000 ETF1.87%956,6443.89MOct 30, 2024
Vanguard Extended Market Index Fund1.17%600,1752.44MSep 29, 2024
Fidelity Small Cap Index Fund0.79%404,5081.65MAug 30, 2024
College Retirement Equities Fund-Stock Account0.56%284,6501.16MSep 29, 2024
Fidelity Extended Market Index Fund0.48%244,669995.80KOct 30, 2024
Advertisement